Ellex works closely with leading physicians and teaching institutions to perfect our technology and intervention methods.

Our ongoing vision is to transform outcomes and quality of life for patients — safely, accurately, effectively and consistently.

Equally as importantly, we’re committed to developing solutions that enable ophthalmologists to focus on proactive patient care through earlier intervention to achieve better results — sustainably and naturally.

Find out more about how we’re achieving new breakthroughs for patients.


Helping physicians to prioritize proactive care

Diabetic Retinopathy

Combatting, restoring — naturally

View treatments

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More


Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.

The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.